FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114465684> ?p ?o ?g. }

• W2114465684 endingPage "2243" @default.
• W2114465684 startingPage "2243" @default.
• W2114465684 abstract "Several clinical trials have evaluated the effects of lipid-lowering medications on coronary heart disease (CHD). Many of the trials have not included enough women to allow sex-specific analyses or have not reported results in women separately.To assess and synthesize the evidence regarding drug treatment of hyperlipidemia for the prevention of CHD events in women and to conduct a meta-analysis of the effect of drug treatment on mortality.We searched MEDLINE, the Cochrane Database, and the Database of Abstracts of Reviews of Effectiveness for articles published from 1966 through December 2003. We reviewed reference lists of articles and consulted content experts.Studies of outpatients that had a treatment duration of at least 1 year, assessed the impact of lipid lowering on clinical outcomes, and reported results by sex were included. Outcomes evaluated were total mortality, CHD mortality, nonfatal myocardial infarction, revascularization, and total CHD events. Summary estimates of the relative risks (RRs) with therapy were calculated using a random-effects model for patients with and without a previous history of cardiovascular disease.Thirteen studies were included. Six trials included a total of 11 435 women without cardiovascular disease and assessed the effects of lipid-lowering medications. Lipid lowering did not reduce total mortality (RR, 0.95; 95% confidence interval [CI], 0.62-1.46), CHD mortality (RR, 1.07; 95% CI, 0.47-2.40), nonfatal myocardial infarction (RR, 0.61; 95% CI, 0.22-1.68), revascularization (RR, 0.87; 95% CI, 0.33-2.31), or CHD events (RR, 0.87; 95% CI, 0.69-1.09). However, some analyses were limited by too few CHD events in the available trials. Eight trials included 8272 women with cardiovascular disease and assessed the effects of lipid-lowering medications. Lipid lowering did not reduce total mortality in women with cardiovascular disease (RR, 1.00; 95% CI, 0.77-1.29). However, lipid lowering reduced CHD mortality (RR, 0.74; 95% CI, 0.55-1.00), nonfatal myocardial infarction (RR, 0.71; 95% CI, 0.58-0.87), revascularization (RR, 0.70; 95% CI, 0.55-0.89), and total CHD events (RR, 0.80; CI, 0.71-0.91).For women without cardiovascular disease, lipid lowering does not affect total or CHD mortality. Lipid lowering may reduce CHD events, but current evidence is insufficient to determine this conclusively. For women with known cardiovascular disease, treatment of hyperlipidemia is effective in reducing CHD events, CHD mortality, nonfatal myocardial infarction, and revascularization, but it does not affect total mortality." @default.
• W2114465684 created "2016-06-24" @default.
• W2114465684 creator A5063225640 @default.
• W2114465684 date "2004-05-12" @default.
• W2114465684 modified "2023-10-02" @default.
• W2114465684 title "Drug Treatment of Hyperlipidemia in Women" @default.
• W2114465684 cites W1500963439 @default.
• W2114465684 cites W1502524639 @default.
• W2114465684 cites W18289480 @default.
• W2114465684 cites W1965408926 @default.
• W2114465684 cites W1966817707 @default.
• W2114465684 cites W1983625180 @default.
• W2114465684 cites W1993181745 @default.
• W2114465684 cites W1993193423 @default.
• W2114465684 cites W1999388462 @default.
• W2114465684 cites W2012116364 @default.
• W2114465684 cites W2015137536 @default.
• W2114465684 cites W2018229264 @default.
• W2114465684 cites W2024276638 @default.
• W2114465684 cites W2024352468 @default.
• W2114465684 cites W2025612747 @default.
• W2114465684 cites W2025845015 @default.
• W2114465684 cites W2031185570 @default.
• W2114465684 cites W2039275327 @default.
• W2114465684 cites W2043180355 @default.
• W2114465684 cites W2046991199 @default.
• W2114465684 cites W2053235682 @default.
• W2114465684 cites W2071483128 @default.
• W2114465684 cites W2078103515 @default.
• W2114465684 cites W2105187058 @default.
• W2114465684 cites W2106665921 @default.
• W2114465684 cites W2108737548 @default.
• W2114465684 cites W2110171695 @default.
• W2114465684 cites W2112213729 @default.
• W2114465684 cites W2129750583 @default.
• W2114465684 cites W2135577623 @default.
• W2114465684 cites W2135631433 @default.
• W2114465684 cites W2157664837 @default.
• W2114465684 cites W2165044111 @default.
• W2114465684 cites W2165884492 @default.
• W2114465684 cites W2169336862 @default.
• W2114465684 cites W2170388163 @default.
• W2114465684 cites W2177460719 @default.
• W2114465684 cites W2306744213 @default.
• W2114465684 cites W2322095705 @default.
• W2114465684 cites W2414680284 @default.
• W2114465684 cites W3144816857 @default.
• W2114465684 cites W38523360 @default.
• W2114465684 cites W600943705 @default.
• W2114465684 cites W752895202 @default.
• W2114465684 doi "https://doi.org/10.1001/jama.291.18.2243" @default.
• W2114465684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15138247" @default.
• W2114465684 hasPublicationYear "2004" @default.
• W2114465684 type Work @default.
• W2114465684 sameAs 2114465684 @default.
• W2114465684 citedByCount "258" @default.
• W2114465684 countsByYear W21144656842012 @default.
• W2114465684 countsByYear W21144656842013 @default.
• W2114465684 countsByYear W21144656842014 @default.
• W2114465684 countsByYear W21144656842015 @default.
• W2114465684 countsByYear W21144656842016 @default.
• W2114465684 countsByYear W21144656842017 @default.
• W2114465684 countsByYear W21144656842018 @default.
• W2114465684 countsByYear W21144656842019 @default.
• W2114465684 countsByYear W21144656842020 @default.
• W2114465684 countsByYear W21144656842021 @default.
• W2114465684 countsByYear W21144656842022 @default.
• W2114465684 countsByYear W21144656842023 @default.
• W2114465684 crossrefType "journal-article" @default.
• W2114465684 hasAuthorship W2114465684A5063225640 @default.
• W2114465684 hasBestOaLocation W21144656841 @default.
• W2114465684 hasConcept C126322002 @default.
• W2114465684 hasConcept C134018914 @default.
• W2114465684 hasConcept C2779091943 @default.
• W2114465684 hasConcept C2779464278 @default.
• W2114465684 hasConcept C44249647 @default.
• W2114465684 hasConcept C500558357 @default.
• W2114465684 hasConcept C535046627 @default.
• W2114465684 hasConcept C555293320 @default.
• W2114465684 hasConcept C71924100 @default.
• W2114465684 hasConcept C82789193 @default.
• W2114465684 hasConcept C95190672 @default.
• W2114465684 hasConceptScore W2114465684C126322002 @default.
• W2114465684 hasConceptScore W2114465684C134018914 @default.
• W2114465684 hasConceptScore W2114465684C2779091943 @default.
• W2114465684 hasConceptScore W2114465684C2779464278 @default.
• W2114465684 hasConceptScore W2114465684C44249647 @default.
• W2114465684 hasConceptScore W2114465684C500558357 @default.
• W2114465684 hasConceptScore W2114465684C535046627 @default.
• W2114465684 hasConceptScore W2114465684C555293320 @default.
• W2114465684 hasConceptScore W2114465684C71924100 @default.
• W2114465684 hasConceptScore W2114465684C82789193 @default.
• W2114465684 hasConceptScore W2114465684C95190672 @default.
• W2114465684 hasIssue "18" @default.
• W2114465684 hasLocation W21144656841 @default.
• W2114465684 hasLocation W21144656842 @default.
• W2114465684 hasOpenAccess W2114465684 @default.
• W2114465684 hasPrimaryLocation W21144656841 @default.

• next